Related Experiment Videos
[Transmyocardial revascularization with laser]
J Guindo1, J Montiel, I Ramírez
1Servicio de Cardiología, Cirugía Cardíaca, Clínica Quirón, Barcelona.
Insights
Laser transmyocardial revascularization offers a promising alternative for severe angina patients ineligible for conventional treatments. Early results show significant symptomatic improvement and enhanced quality of life in this challenging patient group.
Area of Science:
- Cardiology
- Minimally Invasive Surgery
Context:
- Severe angina pectoris refractory to medical treatment presents a significant clinical challenge.
- Patients with advanced coronary artery disease and poor distal targets are often ineligible for conventional revascularization (PTCA, bypass surgery).
- This demographic experiences a high incidence of poor quality of life, severe complications, hospital admissions, and mortality.
Purpose:
- To evaluate laser transmyocardial revascularization (LTMR) as a therapeutic alternative for patients with severe, refractory angina pectoris.
- To assess the safety and efficacy of LTMR in patients unsuitable for traditional revascularization procedures.
Summary:
- Laser transmyocardial revascularization is a novel surgical option for patients with advanced coronary artery disease.
- Multicentric studies involving over 500 patients show promising results, with mortality rates decreasing from 12% to 5%.
- Clinical experience in Spain since 1996 indicates encouraging outcomes, including significant symptomatic improvement and better quality of life.
Impact:
- LTMR provides a viable treatment option for a difficult-to-treat patient population.
- The procedure demonstrates potential to reduce mortality and improve the quality of life for patients with end-stage coronary artery disease.
- Ongoing research and clinical application are refining the safety and effectiveness of this innovative revascularization technique.
Abstract:
Patients with severe angina pectoris, refractory to medical treatment, in which conventional revascularization (PTCA or bypass surgery) is not possible because they present advanced coronary artery disease with a poor distal bed, account for an important clinical problem due to an increasing incidence, combined with poor quality of life, an elevated risk of severe complications, repeated hospital admissions and high mortality rate. Laser transmyocardial revascularization provides a new therapeutic alternative for these patients. Although up to now there are only a few published series, with a small number of patients, the results obtained in the two ongoing multicentric studies in Europe and the United States (including more than 500 patients at present) are quite promising. It is a simple surgical procedure, but its associated mortality is not to be dismissed (in the beginning 12% and currently 5%), because patients are in an advanced evolutionary stage. In Spain this procedure has been available since April 1996 and the results have been encouraging. In our small series we have noted a significant symptomatic improvement and better quality of life.